Purpose Healthy ageing is associated with higher levels of glutathione. The study aimed to determine whether longterm dietary fortification with cysteine increases cysteine and glutathione pools, thus alleviating age-associated lowgrade inflammation and resulting in global physiological benefits. Methods The effect of a 14-week dietary fortification with cysteine was studied in non-inflamed (NI, healthy at baseline) and in spontaneously age-related low-grade inflamed (LGI, prefrail at baseline) 21-month-old rats. Fifty-seven NI rats and 14 LGI rats received cysteinesupplemented diet (4.0 g/kg of free cysteine added to the standard diet containing 2.8 g/kg cysteine). Fifty-six NI rats and 16 LGI rats received a control alanine-supplemented diet. Results Cysteine fortification in NI rats increased free cysteine (P \ 0.0001) and glutathione (P \ 0.03) in the liver and the small intestine. In LGI rats, cysteine fortification increased total non-protein cysteine (P \ 0.0007) and free cysteine (P \ 0.03) in plasma, and free cysteine (P \ 0.02) and glutathione (P \ 0.01) in liver. Food intake decreased over time in alanine-fed rats (r 2 = 0.73, P = 0.0002), whereas it was constant in cysteine-fed rats (r 2 = 0.02, P = 0.68). Cysteine fortification did not affect inflammatory markers, mortality, body weight loss, or tissue masses. Conclusion Doubling the dietary intake of cysteine in old rats increased cysteine and glutathione pools in selected tissues. Additionally, it alleviated the age-related decline in food intake. Further validation of these effects in the elderly population suffering from age-related anorexia would suggest a useful therapeutic approach to the problem.
Introduction
As the number of older individuals around the world is increasing dramatically, defining optimal nutrition for healthy ageing, i.e., a delay in the development of chronic disease [1] , is an important challenge. Ageing per se and/or age-related diseases are associated with a progressive rise in oxidative stress [2] , which plays a role in the expansion of homeosteny, notably low-grade inflammation and sarcopenia [3] . The main intra-cellular antioxidant is glutathione, and imbalances in glutathione levels per se are thought to play a role in the ageing process [4] . Intracellular glutathione concentration decreases with age in various tissues in ageing rats [5] . Along the same lines, higher levels of glutathione are associated with better physical and mental health in elderly [6, 7] . Thus, dietary treatment aiming at increasing antioxidant pools, such as glutathione levels, could promote a healthy ageing.
Glutathione is a tripeptide composed of glutamic acid, cysteine, and glycine. Intra-cellular glutathione levels are regulated by a complex series of mechanisms, and cysteine is the rate-limiting substrate for glutathione synthesis [8] . Cysteine is obtained from dietary proteins, breakdown of body proteins, and glutathione. It can also be endogenously synthesised from methionine and serine through the transsulfuration pathway. When the endogenous disposal of cysteine is insufficient regarding its metabolic utilizations, it becomes an indispensable amino acid [9] . Indeed, increasing cysteine content of the diet of septic rats allows restoration of the liver glutathione pool [10] and limits body weight loss and muscle wasting [11] . In spite of the fact that interventional studies with the pharmacological molecule N-acetyl-cysteine (NAC) exhibited potential beneficial targeted effects for elderly [12] [13] [14] [15] , health-promoting effects of long-term dietary fortification with cysteine itself remain unevaluated.
The primary objective of the study was to determine whether long-term cysteine fortification would increase cysteine and glutathione levels in healthy (i.e. noninflamed) old rats and consequently prevent age-associated development of inflammation and other adverse outcomes (i.e. towards a prefrail/frail status). The secondary objective was to investigate whether cysteine fortification is able to improve the prefrail status in elderly rats with low-grade inflammation. Biochemical targets were cysteine, glutathione, and inflammatory markers; physiological outcomes were mortality, food intake, and body, tissue, and organ weights.
Materials and methods

Animals
The experiments were conducted in accordance with the French National Research Council's Guidelines for the Care and Use of Laboratory Animals. Wistar male rats were bred in our conventional (non-specific pathogen-free) animal facility (Unité Expérimentale de Nutrition Comparée, INRA, Theix, France). They were maintained in collective cages (3-4 per cage) under controlled conditions (temperature 21°C, relative humidity 55 %, 12-h dark period starting at 20:00) with free access to water and standard diet until the experiment. The standard diet (A04 pellets from Scientific Animal Food and Engineering (SAFE), Villemoisson-sur-Orge, France) was composed of 16 % protein, 3 % fat, 60 % carbohydrate, 12 % water, fibres, vitamins, and minerals.
Experimental design
The effect of a 14-week dietary fortification with cysteine was studied in non-inflamed and low-grade inflamed 21-month-old rats (Fig. 1) .
During the pre-experimental period, plasma concentrations of fibrinogen and a 2 -macroglobulin were measured at the ages of 18, 19, and 20.5 months. Rats were weighed at the beginning and at the end of the pre-experimental period. Apparently ill rats and/or rats that exhibited pathological values of acute-phase proteins (i.e. values predictive of short-term mortality according to our previous observations [16] ) were excluded.
At the age of 21 month, rats were distributed into 2 sets based on hierarchical clustering using Ward distance on the following variables: a 2 -macroglobulin, fibrinogen, body weight, and body weight change during the pre-experimental period [XLSTAT, version 7.5 software (Addinsoft, Paris, France)]. A posteriori, non-inflamed (NI, i.e, healthy at baseline) rats were distinguished from low-grade inflamed (LGI, i.e, prefrail at baseline) rats using an a 2 -macroglobulin plasma threshold of 82 mg/L, which corresponds to the mean plasma level ? 2 SD from adult rats [16] . At baseline, LGI rats did not exhibit any apparent pathologies or pathological levels of a 2 -macroglobulin. They were considered as prefrail because their health status was expected to deteriorate more with ageing than the NI rats. Group names (numbers of rats) were as follows: NIAla (n = 56) and NI-Cys (n = 57) for NI rats receiving Alanine diet Non-inflamed rats (NI-Ala, n = 56) Low-grade-inflamed rats (LGI-Ala, n = 16) Non-inflamed rats (NI-Cys, n = 57) Low-grade-inflamed rats (LGI-Cys, n = 14) Cysteine diet Fig. 1 Experimental design alanine-supplemented (Ala) and cysteine-supplemented (Cys) diets, respectively; and LGI-Ala (n = 16) and LGICys (n = 14) for LGI rats receiving Ala and Cys diets, respectively. Cys and Ala diets were prepared by the supplementation of the standard diet A04 with amino acids and distributed as pellets. Cys diet contained 6.8 g/kg diet, i.e., 2.8 g/kg from dietary proteins plus 4 g/kg as free L-cysteine (Sigma). Cysteine level has been chosen, taking into account the efficient level (11 g/kg diet) in septic rats [11] , and the fact that age-associated inflammation is much lower than in sepsis. The selected cysteine level was in the same range as NAC treatment performed in rats [17] . Ala diet contained 2.8 g/kg diet of cysteine from dietary proteins and 2.9 g/kg diet of free L-alanine (Jerafrance) to make it iso-nitrogenous to Cys diet. Rats were maintained in collective cages (2-3 per cage) and received the experimental diets ad libitum for 14 weeks. Food intake was recorded weekly per cage, and individual daily food intake was calculated according to the number of rats per cage. When a death or a moribund condition occurred in a cage, the corresponding data was eliminated. Blood was sampled from the lateral tail vein following 2, 6, and 13 weeks of supplementation. Plasma was isolated and aliquots were stored at -80°C. After 14 weeks of supplementation (24 month of age), rats were killed under general anaesthesia induced by intra-peritoneal injection of pentobarbital (6 mg/100 g body weight, 0.1 mL/100 g body weight, Sanofi, Libourne, France) by exsanguinations through the abdominal aorta. Aliquots of plasma were collected and stored at -80°C. Posterior leg skeletal muscles, liver, small intestine, colon, and kidneys were rapidly isolated. Small intestine and colon were flushed with ice-cold NaCl (9 g/L). The isolated tissues and organs were blotted dry and weighed. Liver and small intestine were frozen in liquid nitrogen and stored at -80°C until cysteine and glutathione analyses.
Biochemical analyses
Plasma acute-phase proteins, such as a 2 -macroglobulin (CV 18 %), fibrinogen (CV 2 %), albumin (CV 15 %) and LPS-binding protein (LBP, lower detection: 1.56 ng/ml), and serum soluble tumour necrosis factor-alpha receptor-1 (sTNFR-1, lower detection: 15.6 pg/ml, CV 5 %) were measured as previously described [16] . Total glutathione (reduced plus oxidized) was quantified with a spectrophotometer using a standard enzymatic recycling procedure and 5,5
0 -dithio-bis-2-nitrobenzoic acid as oxidant (CV 1 %) [18] . Total non-protein cysteine (cysteine plus cystine and cysteine bound to proteins through disulphide bridges) was measured with a colorimeter in plasma or tissue homogenates treated with dithiothreitol before deproteinization (CV 8 %) [19, 20] . Free cysteine (cysteine plus cystine) was quantified with the same method but dithiothreitol treatment was performed after protein precipitation. The difference between total non-protein cysteine and free cysteine provided the protein bound cysteine (cys-prot) value.
Statistical analysis
Survival curves were generated up to 13 weeks of dietary treatment by the Kaplan-Meyer method and compared by log-rank test. Other data are given as mean ± SEM. Linear regression was used to assess the relationship between mean food intake and time. Since rats were housed in collective cages and NI and LGI subgroups were made a posteriori, for this analysis, NI and LGI subgroups were combined. The Mann-Whitney U test was used to analyse the effects of cysteine fortification: (1) NI-Cys plus LGICys versus NI-Ala plus LGI-Ala, (2) NI-Cys versus NIAla, and (3) LGI-Cys versus LGI-Ala. Differences between NI-Ala and LGI-Ala, and between NI-Cys and LGI-Cys were also analysed for studying the effect of basal lowgrade inflammation using the Mann-Whitney U test. The Wilcoxon's signed rank test was used to compare paired data obtained at different time points within a group. These nonparametric tests were used since variances were not homogenous for most of the variables. P values B 0.05 were considered significant. Statistical analyses were performed using StatView for Windows, version 5 software (SAS Institute, Cary, NC).
Results
Pre-experimental characteristics of the aged rats
Baseline plasma concentrations of a 2 -macroglobulin and fibrinogen, body weight, and body weight change from NICys and LGI-Cys rats were not significantly different from those of respective Ala groups (Table 1 ). According to the experimental design, baseline concentrations of a 2 -macroglobulin were significantly higher in LGI rats than in NI rats, being 471 % higher in LGI-Ala rats and 436 % higher in LGI-Cys rats than in the corresponding NI groups. In the same way, baseline concentrations in fibrinogen were 27 % higher in LGI-Ala rats and 39 % higher in LGI-Cys rats than in the corresponding NI groups. Body weight and body weight change during the pre-experimental period were not significantly different between LGI-Ala and LGICys groups.
LGI-Ala rats were lighter than NI-Ala rats, reflecting that LGI-Ala had lost body weight during the pre-experimental period.
Mortality during dietary treatments
During the experimental period, mortality rate was 12, 9, 31, and 43 % in NI-Ala, NI-Cys, LGI-Ala, and LGI-Cys groups, respectively. As expected, comparison of the survival curves generated by Kaplan-Meyer method (not shown) indicated that mortality was higher in LGI-Ala and LGI-Cys rats (prefrail at baseline) than in the corresponding NI groups (healthy at baseline) (log-rank test = 2.79, P = 0.095 and log-rank test = 4.95, P = 0.026, respectively). Mortality was not significantly different between NI-Ala and NI-Cys rats (log-rank test = 0.134, P = 0.71), neither between LGI-Cys and LGI-Ala rats (log-rank test = 0.035, P = 0.85). All the results described below were obtained from the survivors (i.e. NI-Ala, n = 49; NI-Cys, n = 52; LGI-Ala, n = 11; and LGI-Cys, n = 8).
Food intake, body weight, and organ weights Food intake of rats fed with Ala diet (NI-Ala plus LGI-Ala rats) decreased over time (P = 0.0002), whereas it was constant in rats fed with Cys diet (NI-Cys plus LGI-Cys) (Fig. 2) . From week 6 to week 13, the food intake was 3-16 % higher in Cys-fed rats than in Ala-fed rats (P \ 0.0001-0.03).
Final body weight was not significantly different between NI-Ala and NI-Cys rats (P = 0.22), neither between LGI-Ala and LGI-Cys rats (P = 0.87) ( Table 2) . Final body weight of LGI-Ala and LGI-Cys rats (prefrail at baseline) was, respectively, 11 and 15 % lower than in the corresponding NI groups (healthy at baseline).
Absolute and relative weights of liver were, respectively, 10 and 8 % higher in NI-Cys rats than in NI-Ala rats, but were not significantly different between LGI-Ala and LGI-Cys rats (Table 2 ). Liver relative weight in LGIAla and LGI-Cys rats was, respectively, 23 and 20 % higher than in corresponding NI groups. Absolute and relative weights of small intestine and colon were not significantly different between NI-Ala and NI-Cys rats, neither between LGI-Ala and LGI-Cys rats. Relative weight of small intestine, and absolute and relative weight of colon were, respectively, 30, 12, and 27 % higher in LGI-Ala rats than in NI-Ala rats.
Cysteine fortification had no significant effect on kidney or skeletal muscle weights whatever the basal inflammatory status of the rats (not shown). Kidney weight in LGIAla and LGI-Cys rats was, respectively, 34 and 26 % higher than in the corresponding NI groups. Differences between LGI groups and the corresponding NI groups were not significant for all studied skeletal muscles, excepted for EDL, which was 10 % lighter in LGI-Cys rats than in NICys rats (P = 0.043).
Cysteine concentrations in plasma and splanchnic tissues
Plasma total non-protein cysteine concentration was not significantly different between NI-Ala and NI-Cys rats (P = 0.47), but was 40 % higher in LGI-Cys rats than in LGI-Ala rats (Fig. 3) . This variation reveals a corrective effect of dietary cysteine supplementation in rats being prefrail at baseline, since plasma total non-protein cysteine concentration was 21 % lower in LGI-Ala rats than in NIAla rats. Plasma free cysteine (i.e. cysteine plus cystine) concentration in LGI-Cys rats was 50 % higher than in LGI-Ala rats and 23 % higher than in NI-Cys rats. Cysteine LGI-Ala (n = 16)
LGI-Cys (n = 14) Data are mean ± SEM *, **, *** Different from corresponding NI group P \ 0.02, P \ 0.001, P \ 0.0001, respectively fortification did not significantly modify the amount of cysteine bound to plasma proteins through disulphide bridges (cys-prot). Nevertheless, this parameter was 34 % lower in LGI-Ala rats than in NI-Ala rats.
Total non-protein cysteine and cys-prot concentrations in liver and small intestine were not significantly affected by cysteine fortification, neither by the basal inflammatory status (Figs. 4a, 5a ). In the liver, free cysteine concentration was significantly higher in the Cys-supplemented rats than in the Ala rats: 16 and 44 % higher in NI-Cys and LGI-Cys rats than in the corresponding Ala groups. In addition, free cysteine concentration in the liver was 16 % lower in LGI-Ala rats than in NI-Ala rats. In the small intestine, free cysteine concentration was 24 % higher in NI-Cys rats than in NI-Ala rats.
Splanchnic tissues glutathione concentrations and liver c-glutamylcysteine synthetase activity Liver glutathione concentration was significantly higher in Cys-supplemented rats than in the Ala rats: 15 and 20 % higher in NI-Cys and LGI-Cys rats than in the corresponding Ala groups. It was lower in rats being prefrail at baseline than in rats being healthy at baseline: 12 and 8 % lower in LGI-Ala and LGI-Cys rats than in the corresponding NI groups (Fig. 4b) . Liver c-glutamylcysteine synthetase activity was significantly lower in Cys-supplemented rats that in the Ala rats: 32 and 68 % lower in NICys and LGI-Cys rats than in the corresponding Ala groups (Fig. 4c) . This enzyme activity was 45 % higher in LGIAla rats than in NI-Ala rats.
Small intestine glutathione concentration was 3 % higher in NI-Cys rats than in NI-Ala rats and 5 % higher in LGI-Ala rats than in NI-Ala rats (Fig. 5b) .
Acute-phase proteins and sTNFR-1 responses to cysteine fortification
At any time points of the kinetic (week -2, week 2, week 6, and week 13), plasma a 2 -macroglobulin and fibrinogen concentrations were not significantly different between NIAla and NI-Cys rats and neither between LGI-Ala and LGI-Cys rats (P = 0.09-0.94) (Fig. 6) . As expected, a 2 -macroglobulin and fibrinogen were significantly higher in LGI-Ala and LGI-Cys rats (prefrail at baseline) than in the corresponding NI groups (healthy at baseline). Timedependent increases in a 2 -macroglobulin and fibrinogen concentrations were observed in all groups: (1) final a 2 -macroglobulin concentration was significantly higher than its basal value by 582, 670, 488, and 680 % in NI-Ala, NICys, LGI-Ala, and LGI-Cys rats, respectively, and (2) final fibrinogen concentration was significantly higher than its basal value by 36, 53, 48, and 32 % in NI-Ala, NI-Cys, LGI-Ala, and LGI-Cys rats, respectively. Table 2 Effects of cysteine fortification on body and organ weights in old rats being non-inflamed or low-grade inflamed at baseline Group NI-Ala (n = 49) NI-Cys (n = 52)
LGI-Ala (n = 11)
LGI-Cys (n = 8) Data are mean ± SEM Different from NI-Ala P \ 0.03 *, **, *** Different from corresponding NI group P \ 0.05, P \ 0.01, P \ 0.001, respectively Plasma LBP and sTNFR-1 concentrations were quantified at week -2, week 6, and week 13 (data not shown). At any time points, no significant difference in the levels of LBP or sTNFR-I was observed between NI-Ala and NI-Cys rats and neither between
LGI-Ala and LGI-Cys rats (P = 0.07-0.80). Time-dependent increases in LBP and sTNFR-1 concentrations were observed in all groups: (1) final LBP concentration was higher than its basal value by 114, 59, 222, and 167 % in NI-Ala, NI-Cys, LGI-Ala, and LGI-Cys rats, respectively, (2) final sTNFR-1 concentration was higher than its basal value by 102, 79, 153, and 191 % in NI-Ala, NI-Cys, LGI-Ala, and LGI-Cys rats, respectively.
Concentration of plasma albumin quantified at euthanasia was not significantly different between NI-Ala and NI-Cys rats and neither between LGI-Ala and LGI-Cys rats (data not shown). As expected, it was lower in rats being prefrail at baseline than in rats being healthy at baseline: 31 and 30 % lower in LGI-Ala and LGI-Cys rats than in, respectively, NI groups. A strong correlation was observed between plasma albumin and plasma cys-prot concentrations (r 2 = 0.277, P \ 0.0001).
Discussion
To our knowledge, this is the first study to determine whether long-term (14 weeks) cysteine fortification (6.8 vs. Different from corresponding Ala group P \ 0.03 and P \ 0.0001, respectively 2.8 g/kg) can exert beneficial effects in NI (i.e. healthy at baseline) and LGI (i.e. prefrail at baseline) old rats. This is also the first study reporting that cysteine supplementation in the diet increased the spontaneous food intake of old rats.
In NI (i.e. healthy at baseline) rats, cysteine fortification was efficient to increase free cysteine and glutathione pools in liver and small intestine. In agreement with the idea that ageing is a cysteine-deficient syndrome [21] , these increases could result from a correction of age-induced decrease in cysteine and glutathione pools. One cannot rule out an accumulation above normal ranges. However, such an accumulation is rather unlikely for cysteine due to the strong regulation of free cysteine pool by oxidation and degradation, mainly by cysteine dioxygenase [22] . The increase in glutathione pool in liver is consistent with the fact that NAC supplementation (3 g/kg diet) was efficient to reverse the age-associated decrease in liver glutathione in old rats [17] . Similarly, in an elderly cohort, supplementation with NAC and glycine for 3 weeks restored the concentration and the rate of synthesis of blood glutathione [15] . In the present study, the observed increase in liver glutathione pool could directly result from an increase in free cysteine since the availability of cysteine is a ratelimiting factor for glutathione synthesis [23] . The finding of reduced c-glutamylcysteine synthetase activity with cysteine fortification further ruled out the possibility of an increase in its activity as the underlying cause for increased glutathione levels. The most logical explanation for this reduction in enzyme activity is the feedback inhibition exerted by glutathione itself [4] . In a previous study, heat treatment plus NAC also resulted in a similar inhibition of c-glutamylcysteine synthetase activity [24] . Following increased glutathione concentration in the liver, a subsequent increase in the hepatic efflux rate and a more favourable uptake of glutathione by extra-hepatic tissues are expected. This would result in better protection against pathological oxidative challenges in aged rats, but this remains untested. Regardless of the mechanism, cysteine fortification-induced increases in free cysteine and glutathione pools in liver and small intestine did not affect the kinetics of inflammatory markers in rats that were healthy at baseline. This is in contrast to the reported effects of NAC in other models [12, 25, 26] . Further, cysteine fortification-induced effects on cysteine and glutathione pools did not affect final organ, muscle or body weights (except increase in liver weight), or mortality rate in rats that were healthy at baseline. This lack of an effect on body weight rejects the potential relationship between dietary cysteine and obesity [27] . The absence of exercise in the experimental protocol may explain the lack of effect on the skeletal muscle weight. Indeed, NAC supplementation plus physical activity has been reported to improve muscular performance, especially in frail elderly subjects with poor plasma arginine levels [12] . Altogether, the present results support that a deficiency in cysteine or glutathione is not a key player in the age-associated development of inflammation in rats that are healthy at baseline. It rather reflects the development of a subclinical pathology as attested by the increased levels of inflammatory markers reached at the end of the experiment. It has already been stressed that the distinction between ageing per se and age-associated pathology is almost impossible [28] .
In LGI (i.e. prefrail at baseline) rats, the major effects of cysteine fortification were similar to those observed in NI rats that were healthy at baseline, i.e, an increase in plasma free and total non-protein cysteine pools, an increase in free cysteine and glutathione pools along with a decrease in the activity of c-glutamylcysteine synthetase in the liver. These effects of cysteine fortification are considered beneficial since most of these parameters were altered in lowgrade inflamed rats compared to healthy ones (i.e. in LGIAla vs. NI-Ala groups). Nevertheless, cysteine fortification did not alleviate the progression of inflammation in rats that showed low-grade inflammation at baseline. The mortality rate of LGI rats was higher than that of NI rats, and LGI survivors exhibited a lower body weight, higher intestine, and kidneys weights than the NI survivors. At the Labelled bars within a group without a common letter differ, P \ 0.05. end of the experiment, the inflammatory markers of LGI rats reached pathological levels [16] . These observations confirm that basal low-grade inflammation is a predictive factor of frailty and increased mortality [16, [29] [30] [31] . Altogether, cysteine fortification did not stop the progression from prefrailty to frailty, and the basal low-grade inflammation seems to be a likely consequence of nascent pathologies.
The most unexpected result of our experiment was that cysteine fortification alleviated the age-associated decrease in food intake. Our data clearly show that the progressive age-related decrease in food intake observed in ageing rats was suppressed when the animals were supplemented with cysteine. This beneficial effect could be of great importance since decreased food intake has been reported as a robust factor in predicting mortality in hospitalized patients, being even superior to weight loss [32] . While further validation of this effect would be prudent, published data do indeed support such an effect. In a model of LPSinduced anorexia in mice, it has been shown that food intake is higher when brain glutathione is higher [33] . Brain antioxidative defences, notably glutathione, are known to decrease with age [34] . It is possible that the increased availability of cysteine in old rats receiving cysteine fortification allowed a better transport of cysteine into the brain and/or a higher synthesis of glutathione in this organ. Indeed, the transport of cysteine into the brain has been shown to be an important determinant of brain glutathione [35] . In addition, NAC supplementation led to an enhancement of glutathione concentration in brain [14] . These data suggest that the maintenance of food intake in our Cys-supplemented rats is due to an increase in brain glutathione. Unfortunately, this hypothesis cannot be confirmed since no brain sampling was performed in the present study. Other mechanisms cannot be ruled out, notably those related to pro-inflammatory cytokines playing a role in anorexia [36] . Such cytokines have been shown to be decreased in brain of aged rats receiving NAC along with a-tocopherol and a-lipoic acid [37] .
In conclusion, long-term cysteine fortification, leading to the doubling of its dietary supply, appears to be safe (mortality and organ weights unchanged) and efficient in increasing the size of cysteine and glutathione pools in rats that were either healthy or prefrail at baseline. Unfortunately, it did not counteract the development of inflammation in rats that were non-inflamed at baseline nor did it stop the progression of inflammation in rats that showed low-grade inflammation at baseline. Age-associated inflammation seems to be rather a marker of subclinical and clinical pathology than a consequence of a possible cysteine/glutathione deficiency. The novel finding of the study, which needs to be confirmed, was that cysteine fortification inhibited the age-associated anorexia.
